| Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy D Finzi, M Hermankova, T Pierson, LM Carruth, C Buck, RE Chaisson, ... Science 278 (5341), 1295-1300, 1997 | 3771 | 1997 |
| Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin RM Schowalter, DV Pastrana, KA Pumphrey, AL Moyer, CB Buck Cell host & microbe 7 (6), 509-515, 2010 | 681 | 2010 |
| Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan JN Roberts, CB Buck, CD Thompson, R Kines, M Bernardo, PL Choyke, ... Nature medicine 13 (7), 857-861, 2007 | 664 | 2007 |
| Carrageenan is a potent inhibitor of papillomavirus infection CB Buck, CD Thompson, JN Roberts, M Müller, DR Lowy, JT Schiller PLoS pathogens 2 (7), e69, 2006 | 597 | 2006 |
| Efficient intracellular assembly of papillomaviral vectors CB Buck, DV Pastrana, DR Lowy, JT Schiller Journal of virology 78 (2), 751-757, 2004 | 597 | 2004 |
| Arrangement of L2 within the papillomavirus capsid CB Buck, N Cheng, CD Thompson, DR Lowy, AC Steven, JT Schiller, ... Journal of virology 82 (11), 5190-5197, 2008 | 473 | 2008 |
| Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18 DV Pastrana, CB Buck, YYS Pang, CD Thompson, PE Castle, ... Virology 321 (2), 205-216, 2004 | 429 | 2004 |
| Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays YL Tolstov, DV Pastrana, H Feng, JC Becker, FJ Jenkins, S Moschos, ... International journal of cancer 125 (6), 1250-1256, 2009 | 404 | 2009 |
| Maturation of papillomavirus capsids CB Buck, CD Thompson, YYS Pang, DR Lowy, JT Schiller Journal of virology 79 (5), 2839-2846, 2005 | 386 | 2005 |
| The papillomavirus major capsid protein L1 CB Buck, PM Day, BL Trus Virology 445 (1-2), 169-174, 2013 | 352 | 2013 |
| Generation of HPV pseudovirions using transfection and their use in neutralization assays CB Buck, DV Pastrana, DR Lowy, JT Schiller Human Papillomaviruses: Methods and Protocols, 445-462, 2006 | 338 | 2006 |
| Human α-defensins block papillomavirus infection CB Buck, PM Day, CD Thompson, J Lubkowski, W Lu, DR Lowy, ... Proceedings of the National Academy of Sciences 103 (5), 1516-1521, 2006 | 329 | 2006 |
| Quantitation of human seroresponsiveness to Merkel cell polyomavirus DV Pastrana, YL Tolstov, JC Becker, PS Moore, Y Chang, CB Buck PLoS pathogens 5 (9), e1000578, 2009 | 306 | 2009 |
| Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection TC Pierson, Y Zhou, TL Kieffer, CT Ruff, C Buck, RF Siliciano Journal of virology 76 (17), 8518-8531, 2002 | 305 | 2002 |
| A protective and broadly cross-neutralizing epitope of human papillomavirus L2 R Gambhira, B Karanam, S Jagu, JN Roberts, CB Buck, I Bossis, H Alphs, ... Journal of virology 81 (24), 13927-13931, 2007 | 279 | 2007 |
| Taxonomical developments in the family Polyomaviridae R Johne, CB Buck, T Allander, WJ Atwood, RL Garcea, MJ Imperiale, ... Archives of virology 156, 1627-1634, 2011 | 276 | 2011 |
| The Human Immunodeficiency Virus Type 1gag Gene Encodes an Internal Ribosome Entry Site CB Buck, X Shen, MA Egan, TC Pierson, CM Walker, RF Siliciano Journal of virology 75 (1), 181-191, 2001 | 246 | 2001 |
| Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication TC Pierson, TL Kieffer, CT Ruff, C Buck, SJ Gange, RF Siliciano Journal of virology 76 (8), 4138-4144, 2002 | 234 | 2002 |
| The ancient evolutionary history of polyomaviruses CB Buck, K Van Doorslaer, A Peretti, EM Geoghegan, MJ Tisza, P An, ... PLoS pathogens 12 (4), e1005574, 2016 | 222 | 2016 |
| Mash Screen: high-throughput sequence containment estimation for genome discovery BD Ondov, GJ Starrett, A Sappington, A Kostic, S Koren, CB Buck, ... Genome biology 20, 1-13, 2019 | 218 | 2019 |
John T. SchillerNational Caner Institute, NIH在 mail.nih.gov 的电子邮件经过验证
